SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : WR's Momentum Trades
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wayne Rumball who wrote (1612)12/23/1998 2:55:00 PM
From: khrnyc  Read Replies (1) of 11130
 
Wayne,

Thanks for MLRE last week. I'd like to return the favor. Take a look at KERA. On January 12 they will have an FDA panel meeting for a non-laser surgical correction for nearsightedness. In their studies, 74% of folks having the procedure achieved 20/20 or better and 97% achieved 20/40 vision--the standard for receiving a driver's license in most states. If the procedure is approved, they will then compete in the vision correction market with companies like VISX (compare the relative market caps). Recent volume has generally been low and there hasn't been an SI post for Kera since Nov 17th. I think there should be increasing interest in KERA as we approach the panel meeting. I'm long KERA and as always, one should do their own due diligence.

Thanks again for a good thread,
Keith
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News